MENU
BME
ETF ticker:
PRICE
CHANGE
NET ASSETS

BME stock forecast, quote, news & analysis

Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
BME
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for BME with price predictions
Oct 15, 2026

BME's RSI Oscillator ascends from oversold territory

The RSI Oscillator for BME moved out of oversold territory on October 07, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 27 of the 31 cases the stock moved higher. This puts the odds of a move higher at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on BME as a result. In 58 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.

The Moving Average Convergence Divergence (MACD) for BME just turned positive on October 14, 2026. Looking at past instances where BME's MACD turned positive, the stock continued to rise in 41 of 54 cases over the following month. The odds of a continued upward trend are 76%.

BME moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where BME advanced for three days, in 272 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

BME may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for BME crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BME declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

The Aroon Indicator for BME entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Industry description

Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.

Volume

The average weekly volume growth across all stocks in the Blackrock Health Sciences Trust ETF was 1%. For the same stocks of the ETF, the average monthly volume growth was 35% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 19
P/E Growth Rating: 45
Price Growth Rating: 32
SMR Rating: 46
Profit Risk Rating: 57
Seasonality Score: 31 (-100 ... +100)
BME's RSI Oscillator ascends from oversold territory